Message from the CEO
The devotion, expertise, and degree of professionalism employed by the (Altasciences) team in all stages of development, and the support provided during the Clinical trial, were unprecedented.
Read the Blog
October 31, 2019
Drugs are a critical part of the prevention and treatment of diseases. While drug treatments are necessary for their positive impact on the quality of patients’ lives, the increasing number of drugs available on the market means a greater potential for drug-drug interactions (DDIs).
Related Press Release
Nov 12, 2019
Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based in Altasciences’ preclinical facility in Seattle, WA.
Safety assessments for both small and large molecules
Clinical pharmacology trials from first-in-human to end of Phase II
As part of our full service offering or as standalone solutions